ABCHECK S.R.O.
AbCheck s.r.o provides a unique source of therapeutic antibodies with one of the industry's most versatile technology platforms. We provide high-quality drug candidates through discovery collaborations or strategic research partnerships based on flexible business terms including royalty-free agreements. We generate target specific human antibody domains which can be used in distinct therapeutic formats. AbCheck was founded in 2009 and is a spin-out of Affimed’s technology discovery platform. AbCheck is a wholly owned subsidiary of Affimed GmbH, a biopharmaceutical company developing highly targeted cancer immunotherapies.
ABCHECK S.R.O.
Industry:
Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
Plzen, Plzensky Kraj, Czech Republic
Country:
Czech Republic
Website Url:
http://www.abcheckantibodies.com
Status:
Active
Contact:
+420 378 05 15 00
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache Wordpress Plugins Sitelinks Search Box Yoast WordPress SEO Plugin
Official Site Inspections
http://www.abcheckantibodies.com Semrush global rank: 4.99 M Semrush visits lastest month: 1.69 K
- Host name: 241.194.forpsi.net
- IP address: 81.2.194.241
- Location: Ktis Czechia
- Latitude: 48.9167
- Longitude: 14.1333
- Timezone: Europe/Prague
- Postal: 383 01
More informations about "AbCheck s.r.o."
AbCheck - Crunchbase Company Profile & Funding
AbCheck provides an antibody discovery platform that discovers and optimizes …See details»
Ampersand Biomedicines Acquires AbCheck to Accelerate …
I look forward to seamlessly integrating AbCheck’s broad antibody discovery capabilities and experienced team as one organization and together building a pipeline of drug candidates that …See details»
AbCheck 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for …See details»
AbCheck - 2025 Company Profile & Competitors - Tracxn
Jun 27, 2025 AbCheck is an acquired company based in Pilsen (Czech Republic), founded in 2009. It operates as a Developer of human therapeutic antibodies. The company has 10 active …See details»
AbCheck Company Profile - Office Locations, Competitors ... - Craft
AbCheck has 5 employees at their 1 location. See insights on AbCheck including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck
Mannheim, Germany, January 3, 2024 – Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back …See details»
Ampersand Biomedicines Acquires AbCheck to Accelerate …
Jan 3, 2024 I look forward to seamlessly integrating AbCheck’s broad antibody discovery capabilities and experienced team as one organization and together building a pipeline of drug …See details»
Ampersand Biomedicines Acquires AbCheck - citybiz
Jan 3, 2024 I look forward to seamlessly integrating AbCheck’s broad antibody discovery capabilities and experienced team as one organization and together …See details»
AbCheck | VentureRadar
Syngene is an innovation-led contract research, development, and manufacturing organization offering integrated scientific services from early discovery to commercial supply. The company …See details»
AbCheck s.r.o., a Leader in Providing Antibody Drug Discovery and ...
Shelly Adams, Vice President of Business Development to lead the commercial efforts Plzen, Czech Republic, and San Diego, CA United States October 30, 2018 – AbCheck s.r.o., a …See details»
Ampersand Biomedicines. (1/3/24). "Press Release: Ampersand ...
I look forward to seamlessly integrating AbCheck’s broad antibody discovery capabilities and experienced team as one organization and together building a pipeline of drug candidates that …See details»
Ampersand Biomedicines acquires AbCheck - 2024-01-03
Recent News News • Jan 4, 2024 abcheckantibodies.com — Ampersand Biomedicines Acquires AbCheck to Accelerate Platform and Product Development News • Jan 3, 2024 ampersand.bio …See details»
AbCheck S.R.O., a Leader in Providing Antibody Drug Discovery …
Oct 30, 2018 For additional information on AbCheck's contract discovery and optimization services with monoclonal antibodies, visit https://abcheckantibodies.com, or email us at info …See details»
Disruptive Antibody Discovery & Development Solutions for …
Disruptive Antibody Discovery & Development Solutions for Challenging Targets Company PresentationSee details»
AbCheck s.r.o. - life-sciences-europe.com
AbCheck discovers and optimizes human therapeutic antibodies with one of the industry’s most versatile technology platforms. Tailored to specific needs and desired Target Product Profiles, …See details»
AbCheck sro - Drug pipelines, Patents, Clinical trials - Synapse
Strategic Restructuring Affimed also announced today a restructuring initiative aimed at transforming the Company into a focused clinical organization, positioned to successfully …See details»
230309_AbCheck_Grant_PR_final - abcheckantibodies.com
AbCheck Announces Successful Completion of Research and Development Under Grant to Develop a Novel Microfluidics Technology for Functional Antibody Discovery Plzen, Czech …See details»
AbCheck Announces Successful Completion of Research and …
AbCheck Announces Successful Completion of Research and Development Under Grant to Develop a Novel Microfluidics Technology for Functional Antibody Discovery Plzen, Czech …See details»
Technologies - AbCheck
AbCheck offers a variety of services and technologies to meet the increased demand for high-quality antibody development candidates in today’s antibody discovery world, where drug …See details»
AbCheck s.r.o. Receives Grant to Further Develop a Discovery …
AbCheck s.r.o. Receives Grant to Further Develop a Discovery Technology for Functional Antibodies using Microfluidics Pilsen, Czech Republic, October 6, 2020 - AbCheck s.r.o., a …See details»